Dzien A - Search Results

1

Evaluation of a new insulinotropic agent by using an innovative technology: efficacy and safety of nateglinide determined by continuous glucose monitoring.

Abrahamian H, Francesconi M, Loiskandl A, Dzien A, Prager R, Weitgasser R. Abrahamian H, et al. Among authors: dzien a. Diabetes Technol Ther. 2004 Feb;6(1):31-7. doi: 10.1089/152091504322783387. Diabetes Technol Ther. 2004. PMID: 15000767 Clinical Trial.

2

Fasting glucose and increasing age.

Dzien A, Dzien-Bischinger C, Lechleitner M. Dzien A, et al. Among authors: dzien bischinger c. Diabetes Obes Metab. 2001 Aug;3(4):297-8. doi: 10.1046/j.1463-1326.2001.00135.x. Diabetes Obes Metab. 2001. PMID: 11520311 No abstract available.

3

The metabolic syndrome as a link between smoking and cardiovascular disease.

Dzien A, Dzien-Bischinger C, Hoppichler F, Lechleitner M. Dzien A, et al. Among authors: dzien bischinger c. Diabetes Obes Metab. 2004 Mar;6(2):127-32. doi: 10.1111/j.1462-8902.2004.00324.x. Diabetes Obes Metab. 2004. PMID: 14746578

4

The correlation of office blood pressure and 24-hour ambulatory measurements in hypertensive patients - comparison between non-pharmacological treatment and antihypertensive medication.

Dzien A, Pfeiffer K, Dzien-Bischinger C, Hoppichler F, Lechleitner M. Dzien A, et al. Among authors: dzien bischinger c. Eur J Med Res. 2000 Jun 20;5(6):268-72. Eur J Med Res. 2000. PMID: 10882643

5

Fasting glucose concentrations and cardiovascular [correction of cardiovasular] disease; are the new diagnostic criteria not strict enough?

Dzien A, Dzien-Bischinger C, Hoppichler F, Lechleitner M. Dzien A, et al. Among authors: dzien bischinger c. Diabetes Res Clin Pract. 2001 Dec;54(3):213-4. doi: 10.1016/s0168-8227(00)00243-6. Diabetes Res Clin Pract. 2001. PMID: 11689277 No abstract available.

6

The influence of obesity on the frequency and distribution of medication.

Dzien A, Pfeiffer KP, Dzien-Bischinger C, Hoppichler F, Lechleitner M. Dzien A, et al. Among authors: dzien bischinger c. Acta Med Austriaca. 2003;30(2):51-4. doi: 10.1046/j.1563-2571.2003.03005.x. Acta Med Austriaca. 2003. PMID: 12752089

7

Fat-free mass and fasting glucose values in patients with and without statin therapy assigned to age groups between <60 and >75 years.

Dzien A, Winner H, Theurl E, Dzien-Bischinger C, Lechleitner M. Dzien A, et al. Obes Facts. 2013;6(1):9-16. doi: 10.1159/000348573. Epub 2013 Feb 21. Obes Facts. 2013. PMID: 23434893 Free PMC article.

8

Long-term effect of intensified insulin treatment on lipid parameters in diabetes mellitus type I.

Dzien A, Lechleitner M, Hopferwieser T, Drexel H, Patsch JR, Braunsteiner H. Dzien A, et al. Klin Wochenschr. 1991 Aug 1;69(11):483-5. doi: 10.1007/BF01649419. Klin Wochenschr. 1991. PMID: 1921231

9

Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors.

Lechleitner M, Koch T, Herold M, Dzien A, Hoppichler F. Lechleitner M, et al. Among authors: dzien a. J Intern Med. 2000 Jul;248(1):67-76. doi: 10.1046/j.1365-2796.2000.00705.x. J Intern Med. 2000. PMID: 10947883 Free article.

10

Body mass index in a large cohort of patients assigned to age decades between <20 and ≥80 years: relationship with cardiovascular morbidity and medication.

Dzien A, Winner H, Theurl E, Dzien-Bischinger C, Lechleitner M. Dzien A, et al. Among authors: dzien bischinger c. J Nutr Health Aging. 2011 Aug;15(7):536-41. doi: 10.1007/s12603-011-0055-z. J Nutr Health Aging. 2011. PMID: 21808931 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters